The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dextrose and Electrolyte No. 48
Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride and Dextrose monohydrate · DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM LACTATE 260 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; MAGNESIUM CHLORIDE 31 mg/100mL; POTASSIUM PHOSPHATE, MONOBASIC 20 mg/100mL; SODIUM CHLORIDE 12 mg/100mL · Injection · Intravenous · Baxter Healthcare Company
NDC 00338-0143-03 · 500 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$7.92
Reported to Texas DSHS · 2026 annual filing · Baxter Healthcare Corporation
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$532
56 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA017484
- TE code
- —
- Approval date
- Jan 1, 1982
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride and Dextrose monohydrate (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM LACTATE 260 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; MAGNESIUM CHLORIDE 31 mg/100mL; POTASSIUM PHOSPHATE, MONOBASIC 20 mg/100mL; SODIUM CHLORIDE 12 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM LACTATE 31 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; MAGNESIUM CHLORIDE 20 mg/100mL; POTASSIUM PHOSPHATE, MONOBASIC 12 mg/100mL; SODIUM CHLORIDE 260 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 5 g/100mL; MAGNESIUM CHLORIDE 31 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; POTASSIUM PHOSPHATE, MONOBASIC 20 mg/100mL; SODIUM CHLORIDE 12 mg/100mL; SODIUM LACTATE 260 mg/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dextrose and Electrolyte No. 48 — NDC 00338-0143-03," retrieved September 3, 2026, https://drugdashboards.com/drug/00338014303.
Free to cite with attribution — see how the data is put together.